About
Shlomi Raz is a biotech founder and finance executive focused on neuropsychiatry, psychedelic-derived therapeutics, and aging-related CNS disease. He is Managing Partner at Negev Labs and Founder & CEO of Ariadne Bio, after previously founding Eleusis and joining Beckley Psytech following Beckley's October 2022 acquisition of Eleusis. Earlier in his career, he was a managing director at Goldman Sachs.
Areas of interest
longevityagingbiotechneuropsychiatrypsychedelic medicineneuroplastogensCNS therapeuticsParkinson's diseaseapathyAlzheimer's diseaseophthalmologydrug developmentbiotech venture buildingpharma licensing